Prosecution Insights
Last updated: July 17, 2026
Application No. 18/005,212

METHOD OF PRODUCING NICKEL-CONTAINING HYDROXIDE, METHOD OF PRODUCING POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERY, POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY

Final Rejection §103
Filed
Jan 12, 2023
Priority
Jul 21, 2020 — JP 2020-124702 +1 more
Examiner
BLACKWELL-RUDASIL, RYAN KENZIE
Art Unit
1722
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sumitomo Metal Mining Co., Ltd.
OA Round
2 (Final)
71%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
12 granted / 17 resolved
+5.6% vs TC avg
Strong +42% interview lift
Without
With
+41.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
31 currently pending
Career history
53
Total Applications
across all art units

Statute-Specific Performance

§103
88.4%
+48.4% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
0.7%
-39.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 17 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-6, 8, and 9 are pending. Claims 1-4 and 9 are withdrawn. Claim 7 is cancelled. Status of Amendment The amendment filed on March 19th, 2026 has been fully considered but does not place the application in condition for allowance. Status of Objections and Rejections Pending Since the Office Action of January 9th, 2026 The 102 rejections of claims 5, 6, and 8 are withdrawn in view of the Applicant's amendment. The 103 rejection of claim 7 is moot because claim 7 has been cancelled. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 5, 6, and 8 are rejected under 35 U.S.C. 103 as being unpatentable over Itou (US 2009/0029253 A1) and further in view of Toya (US 2018/0347069 A1) and Yamauchi (US 2016/0308207 A1). Regarding claims 5 and 6, Itou teaches a positive electrode active material comprising lithium-nickel composite oxide particles [0033] which have a porosity in a range of 0.2% to 5% [0044][, overlapping with the claimed range of 1% or less (as required by claim 6). In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). See MPEP 2144.05 (I). Although Itou teaches that the active material particles have an average particle size in a range of 0.05 – 20 µm [0047], they fail to teach a range of a D50 average particle size. Toya is analogous art to Itou because both discuss positive active materials for use in lithium-ion batteries. Toya teaches that their average particle size may be a D50 value [0094], and they continue to teach that the particle size may be between 3 and 7 µm [0087]. When the size of the particles is less than 3 µm, the battery capacity per volume decreases. On the other hand, when D50 size is greater than 7 µm, the resistance in the cathode increases [0164]. Therefore, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the present invention to ensure that the D50 value of Itou’s particles remains between 3 – 7 µm to ensure that the battery capacity per volume does not decrease and that the resistance in the cathode does not increase. Furthermore, this range of 3 µm – 7 µm overlaps with the claimed range of 3 µm to 6 µm. In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). See MPEP 2144.05 (I). Itou is also silent on a particle size distribution index where the quotient of (D90 – D10) / (volume average particle size) is between 0.4 and 0.5. Yamauchi is analogous art to Itou because both discuss positive active materials used in lithium-ion batteries. Yamauchi teaches that when the value of (D90 – D10) /MV (where MV means “volume average particle diameter) is more than 0.6, the “problem of the deterioration of the cycling property of the non-aqueous electrolyte secondary battery using the positive electrode” or the “problem of short circuit” arises due to the increase of coarse particles [0111]. Therefore, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the present invention to ensure that the particle size distribution index of Itou’s particles is less than 0.6 to prevent the possibility of the aforementioned problems arising during normal battery operations. Furthermore, the range of “0.6 or less” [0110] overlaps with the claimed range of 0.4 – 0.5. In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). See MPEP 2144.05 (I). Regarding claim 8, Itou discloses a positive active material with the general formula LiaNibCocMndMeOfNg [0037] where the values of the subscripts overlap with the subscripts of the claimed positive active material that that contains of LiaNi1-x-y-z-MnyMz [0038]. Detailed analysis is given below: “a”, the subscript of Li, has a range of 0 < a ≤ 1.2 which overlaps with the claimed range of 0.95 ≤ a ≤ 1.10. “d”, the subscript of Mn, has a range of 0.25 ≤ d ≤ 0.6 which overlaps with the claimed range of 0.1 ≤ x ≤ 0.5. “c”, the subscript of Co, has a range of 0 ≤ c ≤ 0.6 which overlaps with the claimed range of 0 ≤ y ≤ 1/3. “e”, the subscript of M, an additional metal which may represent Mg, Ca, Al, Ti, V, or C, has a range of 0 ≤ e ≤ 0.3, which overlaps with the claimed range of 0 ≤ z ≤ 0.1. “b”, the subscript of Ni, has a range of 0.3 ≤ b ≤ 0.9, which would encompass the value of “1 – x – y – z” as long as “d” ≤ “1 – d – c – e”. One such example of such values would include the following: “d” = 0.33 “c” = 0.33 “e” = 0 “b” = “1 – d – c – e” = 0.34, which is greater than “d” = 0.33 Response to Arguments Applicant’s arguments with respect to claims 5, 6, and 8 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Mori (US 2012/0276454 A1) discusses nickel composite hydroxide particles with an average particle diameter nearly identical to the claimed range (3 µm – 7 µm) as well as a particle size distribution range that overlaps with the claimed range (0.55 or less) [0032]. This reference, however, notably fails to teach the porosity of the material. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RYAN K BLACKWELL-RUDASILL whose telephone number is (571)270-0563. The examiner can normally be reached Monday - Friday 9:00 a.m. - 5:00 p.m. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niki Bakhtiari can be reached at 571-272-3433. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /R.B.R./Examiner, Art Unit 1722 /NIKI BAKHTIARI/Supervisory Patent Examiner, Art Unit 1722
Read full office action

Prosecution Timeline

Jan 12, 2023
Application Filed
Jan 09, 2026
Non-Final Rejection mailed — §103
Mar 19, 2026
Response Filed
May 28, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12620614
Roll for Supporting Electrode and Electrode Manufacturing Apparatus Including the Same
3y 8m to grant Granted May 05, 2026
Patent 12614760
SECONDARY BATTERY AND METHOD OF PRODUCING SAME
3y 10m to grant Granted Apr 28, 2026
Patent 12609358
SECONDARY BATTERY AND METHOD FOR MANUFACTURING THE SAME
3y 10m to grant Granted Apr 21, 2026
Patent 12603379
ENERGY STORAGE SYSTEM
3y 3m to grant Granted Apr 14, 2026
Patent 12597600
LITHIUM SECONDARY BATTERY
3y 4m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
71%
Grant Probability
99%
With Interview (+41.7%)
3y 4m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 17 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month